TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
| TERRI STEWART | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership Trade Agreement; Transatlantic Trade & Investment Partnership Agreement.
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| TERRI STEWART | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.